BE900959A - Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication. - Google Patents

Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication.

Info

Publication number
BE900959A
BE900959A BE0/213934A BE213934A BE900959A BE 900959 A BE900959 A BE 900959A BE 0/213934 A BE0/213934 A BE 0/213934A BE 213934 A BE213934 A BE 213934A BE 900959 A BE900959 A BE 900959A
Authority
BE
Belgium
Prior art keywords
manufacture
substituted prostaglandins
furyl derivatives
prostaglandins
furyl
Prior art date
Application number
BE0/213934A
Other languages
English (en)
Inventor
F Faustini
A Panzeri
F Orzi
E Di Salle
R Ceserani
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of BE900959A publication Critical patent/BE900959A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)

Abstract

Les médicaments selon l'invention répondent à la formule générale I dans laquelle les divers symboles sont définis. Application : pour toutes les indications des prostaglandines naturelles, notamment en association avec des antiinflammatoires inhibiteurs de prostaglandine-synthétase. Administration orale à la dose journalière de 1 à 10 mg en 1 ou 3 prises.
BE0/213934A 1983-11-04 1984-10-31 Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication. BE900959A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838329559A GB8329559D0 (en) 1983-11-04 1983-11-04 Furyl derivatives of 16-substituted prostaglandins preparations

Publications (1)

Publication Number Publication Date
BE900959A true BE900959A (fr) 1985-05-02

Family

ID=10551287

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213934A BE900959A (fr) 1983-11-04 1984-10-31 Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication.

Country Status (18)

Country Link
US (1) US4585791A (fr)
JP (1) JPS60112782A (fr)
AU (1) AU563999B2 (fr)
BE (1) BE900959A (fr)
CH (1) CH663413A5 (fr)
DE (1) DE3439863A1 (fr)
DK (1) DK524484A (fr)
FI (1) FI844273L (fr)
FR (1) FR2554448B1 (fr)
GB (2) GB8329559D0 (fr)
GR (1) GR80822B (fr)
HU (1) HU193708B (fr)
IL (1) IL73395A0 (fr)
IT (1) IT1177095B (fr)
NL (1) NL8403307A (fr)
SE (1) SE8405514L (fr)
SU (1) SU1489582A3 (fr)
ZA (1) ZA848551B (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009131977A1 (fr) * 2008-04-24 2009-10-29 Allergan, Inc. Composés thérapeutiques
WO2009137411A1 (fr) * 2008-05-09 2009-11-12 Allergan, Inc. Composés thérapeutiques
WO2009137412A1 (fr) * 2008-05-09 2009-11-12 Allergan, Inc. Composés thérapeutiques
WO2009137413A1 (fr) * 2008-05-09 2009-11-12 Allergan, Inc. Dérivés thérapeutiques de cyclopentane
WO2009117467A3 (fr) * 2008-03-18 2009-11-12 Allergan, Inc. Composés thérapeutiques
WO2009132093A3 (fr) * 2008-04-24 2009-12-17 Allergan, Inc. Arylcyclopentènes substitués en tant qu'agents thérapeutiques

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834498A (en) * 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US8063033B2 (en) * 2008-01-18 2011-11-22 Allergan, Inc. Therapeutic beta-lactams
US7713967B2 (en) * 2008-05-09 2010-05-11 Allergan, Inc. Therapeutic substituted hydantoins, and related compounds
CN107802623B (zh) * 2012-07-19 2020-10-30 开曼化学股份有限公司 用于ep4介导的骨相关疾病和病症的二氟内酰胺组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
ES416865A1 (es) * 1972-07-13 1976-03-01 Pfizer Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15.
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
IT1088966B (it) * 1977-11-15 1985-06-10 Erba Carlo Spa 13,14-dideidro-prostaglandine
US4543353A (en) * 1981-11-27 1985-09-24 Farmitalia Carlo Erba S.P.A. Ester and amide derivatives of 13,14-didehydro prostaglandins

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009117467A3 (fr) * 2008-03-18 2009-11-12 Allergan, Inc. Composés thérapeutiques
US7960378B2 (en) 2008-03-18 2011-06-14 Allergan, Inc. Therapeutic compounds
WO2009131977A1 (fr) * 2008-04-24 2009-10-29 Allergan, Inc. Composés thérapeutiques
WO2009132093A3 (fr) * 2008-04-24 2009-12-17 Allergan, Inc. Arylcyclopentènes substitués en tant qu'agents thérapeutiques
US7803797B2 (en) 2008-04-24 2010-09-28 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
WO2009137411A1 (fr) * 2008-05-09 2009-11-12 Allergan, Inc. Composés thérapeutiques
WO2009137412A1 (fr) * 2008-05-09 2009-11-12 Allergan, Inc. Composés thérapeutiques
WO2009137413A1 (fr) * 2008-05-09 2009-11-12 Allergan, Inc. Dérivés thérapeutiques de cyclopentane
US7981887B2 (en) 2008-05-09 2011-07-19 Allergan, Inc. Therapeutic compounds
US8530471B2 (en) 2008-05-09 2013-09-10 Allergan, Inc. Therapeutic cyclopentane derivatives
US8569349B2 (en) 2008-05-09 2013-10-29 Allergan, Inc. Therapeutic compounds
AU2009244513B2 (en) * 2008-05-09 2014-04-10 Allergan, Inc. Therapeutic cyclopentane derivatives

Also Published As

Publication number Publication date
HUT35637A (en) 1985-07-29
SU1489582A3 (ru) 1989-06-23
FI844273A0 (fi) 1984-10-31
HU193708B (en) 1987-11-30
FI844273A7 (fi) 1985-05-05
CH663413A5 (de) 1987-12-15
FR2554448B1 (fr) 1987-07-24
NL8403307A (nl) 1985-06-03
JPS60112782A (ja) 1985-06-19
FI844273L (fi) 1985-05-05
IT1177095B (it) 1987-08-26
AU563999B2 (en) 1987-07-30
ZA848551B (en) 1985-06-26
GR80822B (en) 1985-03-04
GB8427678D0 (en) 1984-12-05
SE8405514L (sv) 1985-05-05
GB8329559D0 (en) 1983-12-07
AU3494584A (en) 1985-05-09
FR2554448A1 (fr) 1985-05-10
GB2149788A (en) 1985-06-19
US4585791A (en) 1986-04-29
GB2149788B (en) 1987-04-08
IL73395A0 (en) 1985-02-28
DE3439863A1 (de) 1985-05-23
IT8423390A1 (it) 1986-04-30
SE8405514D0 (sv) 1984-11-02
IT8423390A0 (it) 1984-10-30
DK524484A (da) 1985-05-05
DK524484D0 (da) 1984-11-02

Similar Documents

Publication Publication Date Title
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
YU44058B (en) Process for making derivatives of 2-amino-5-hydroxi-4-methylpyrimidine
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
BE900959A (fr) Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication.
BE904368A (fr) Nouveaux derives de pyridylmethoxy- et methylmercaptoanilines, utiles notamment comme antiasthmatiques, leur fabrication et medicaments les contenant.
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2354761A1 (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
FR2428052A1 (fr) Nouveaux derives de 5-fluoro-(b-uridine ou 2'-desoxy-b-uridine), procede pour les preparer et agents carcinostatiques les renfermant
FR2554346B1 (fr) Ensemble et procede pour l'administration de gangliosides et de leurs derives par inhalation et compositions pharmaceutiques les contenant
FR2362839A1 (fr) Derives de l'hydantoine et medicaments contenant ces substances
FR2422657A1 (fr) 2-(2-thenoylthio)-propionylglycine, procede pour sa preparation et compositions pharmaceutiques la contenant
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
SE8500996D0 (sv) Method of treatment
FR2422405A1 (fr) Nouveaux medicaments constitues de derives de l'acide p-aminobenzoique
FR2417502A1 (fr) Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation
FR2429783A1 (fr) Nouveaux derives de vitamines d et leur application en therapeutique
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
KR890004705A (ko) 항바이러스성 제제
FR2377804A1 (fr) Compositions analgesiques et anti-inflammatoires comprenant des derives de chromone
FR2421616A1 (fr) Nouveaux medicaments constitues de derives de l'acide o-aminobenzoique
EP0093497A3 (fr) Traitement anthelminthique
FR2397387A1 (fr) 4,4'-bis-formyl-polyhalo-diphenoxyalcanes, procede de preparation et application a la synthese de 4,4'-dicyano-polyhalo-diphenoxyalcanes
FR2401139A2 (fr) Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant
BE904864A (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FARMITALIA CARLO ERBA S.P.A.

Effective date: 19881031